RxDoctor Payments Data

Timothy Hagino, MD

Dermatology · Kailua Kona, HINPI 1134220221

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 25.4% of the total. Reporting peaked in 2019 at $708 and has fallen 93.7% since, to $45 in 2025. That places this record below the midpoint for dermatology clinicians in HI, where the typical reported total is $2,082.

$933in general payments, 2019–2025

Across 24 payments — averaging $38.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$237
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$145
  • Genentech USA, Inc.$143
  • Dermira, Inc.$125
  • Sun Pharmaceutical Industries Inc.$77
  • Amgen$70
  • plus $136 from 5 others

What the payments were for

  • Food & beverage$92699%
  • Education$61%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$933 in reported general payments places this provider in the 35th percentile of 67 dermatology providers in Hawaii.

See all dermatology providers in Hawaii

Medicare billing

Part B allowed, 2024
$3,780
Medicare patients
24
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab12$159,499
Dupixent PenDupilumab27$111,317
AdbryTralokinumab-Ldrm20$68,443
Fluorouracil170$6,950
Calcipotriene84$6,486
Imiquimod69$1,851
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc77$1,697
Tacrolimus22$1,342
Triamcinolone Acetonide87$1,143
Clobetasol Propionate30$802
Ketoconazole52$800
Hydrocortisone42$537
Clindamycin Phosphate19$519
Mupirocin40$404
CiclopiroxCiclopirox Olamine18$353

Paid to pharmacies, not to this prescriber.

Other dermatology in Kailua Kona

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →